TABLE 1

Head and Neck Cancer

StudyDesignPatients (n)PET/MRIIndicationT-stagingN-stagingM-stagingSuperiority
Kuhn (28)Prospective150SequentialStaging, restagingNSND
Queiroz (29)Prospective87SequentialRestagingNSNSND
Kubiessa (25)Prospective17SimultaneousStaging, restagingND
Partovi (26)Prospective14SequentialStaging, restagingND
Varoquaux (27)Prospective32SequentialStaging, restagingND
Covello (30)Retrospective44SequentialStaging, restagingNSND
Schaarschmidt (31)Retrospective25SimultaneousStaging, restagingNSNSND
Total369
  • NS = nonsignificant; ND = no difference; — = not reported.